"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 7 | 7 |
| 1996 | 0 | 8 | 8 |
| 1997 | 0 | 13 | 13 |
| 1998 | 0 | 13 | 13 |
| 1999 | 0 | 13 | 13 |
| 2000 | 0 | 6 | 6 |
| 2001 | 0 | 8 | 8 |
| 2002 | 0 | 13 | 13 |
| 2003 | 0 | 15 | 15 |
| 2004 | 0 | 10 | 10 |
| 2005 | 0 | 10 | 10 |
| 2006 | 0 | 14 | 14 |
| 2007 | 0 | 16 | 16 |
| 2008 | 0 | 13 | 13 |
| 2009 | 0 | 13 | 13 |
| 2010 | 0 | 20 | 20 |
| 2011 | 0 | 21 | 21 |
| 2012 | 0 | 18 | 18 |
| 2013 | 0 | 13 | 13 |
| 2014 | 1 | 17 | 18 |
| 2015 | 0 | 23 | 23 |
| 2016 | 0 | 24 | 24 |
| 2017 | 0 | 16 | 16 |
| 2018 | 0 | 34 | 34 |
| 2019 | 0 | 25 | 25 |
| 2020 | 0 | 32 | 32 |
| 2021 | 0 | 28 | 28 |
| 2022 | 0 | 13 | 13 |
| 2023 | 0 | 11 | 11 |
| 2024 | 0 | 20 | 20 |
| 2025 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial. J Antimicrob Chemother. 2025 Oct 03; 80(10):2719-2726.
-
Limosilactobacillus reuteri enables oral-to-systemic absorption of iberiotoxin for treatment of collagen-induced arthritis in rats. Microb Cell Fact. 2025 Aug 02; 24(1):177.
-
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeys. Nat Commun. 2025 Jul 11; 16(1):6437.
-
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and Opportunities. Allergy. 2025 Aug; 80(8):2113-2127.
-
Asthma in the Biologics Era: Should Oral Corticosteroid Therapy Be Relegated to History? J Allergy Clin Immunol Pract. 2025 Jul; 13(7):1559-1568.
-
Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins). J Manag Care Spec Pharm. 2025 Apr; 31(4):396-405.
-
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2025 Mar 17; 31(6):965-974.
-
Marginal structural models to evaluate the association between adherence to direct oral anticoagulants and safety or efficacy outcomes among patients with atrial fibrillation. J Am Pharm Assoc (2003). 2025 May-Jun; 65(3):102355.
-
Infant and Toddler Peanut Oral Immunotherapy: Initiation Before Age 2 Increases Ad Libitum Peanut Consumption. J Allergy Clin Immunol Pract. 2025 Apr; 13(4):885-892.
-
Newer formulations of oral testosterone undecanoate: development and liver side effects. Sex Med Rev. 2025 Jan 31; 13(1):33-40.